The incidence is approximately 0.4% at doses up to 450mg daily, which sounds small until you realize that certain conditions dramatically increase this baseline risk
I would also like to thank EBMT for selecting our study for this award
Common digestive MTHFR symptoms include: IBS (Irritable Bowel Syndrome) alternating constipation and diarrhea, cramping, or abdominal pain Chronic bloating and gas feeling uncomfortable or distended after meals Food sensitivities and intolerances reactions to gluten, dairy, histamine-rich foods, or FODMAPs Leaky gut syndrome increased intestinal permeability leading to systemic inflammation Nausea or acid reflux particularly after eating certain foods Nutrient malabsorption low B12, folate, or iron despite adequate dietary intake Why this happens: Methylation supports detoxification pathways in the liver and helps break down histamine
Thyroid medications require dose adjustment when body weight changes significantly
Read More - #Peptides #HealthcareInnovation #GLP1 #Longevity #HealthTech To view or add a comment, sign in Long-Term Risk: Opioid Analgesics (e.g., Oxycodone, Hydrocodone) Consider how chronic opioid analgesics reshape patient outcomes, prompting us to examine their shared physiological consequences today